Biofoam
Payments companies reported to CMS as associated with Biofoam. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Biofoam, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Biofoam
These are the largest totals companies reported as associated with Biofoam. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Hyer | Worthington, OH | Foot & Ankle Surgery | $25,579.62 |
| Jordan Grossman | Akron, OH | Foot & Ankle Surgery | $8,756.45 |
| Michael Troiano | Philadelphia, PA | Foot & Ankle Surgery | $2,000.00 |
| Andrew Harston | Louisville, KY | Orthopaedic Surgery | $1,949.05 |
| Joseph Daniel | Marlton, NJ | Orthopaedic Surgery | $1,000.00 |
| Timothy Weber | Indianapolis, IN | Orthopaedic Trauma | $485.99 |
| Corey Groh | Indianapolis, IN | Podiatrist | $485.99 |
| William Adams | Greenfield, IN | Foot & Ankle Surgery | $485.99 |
| Thomas Rocchio | Allentown, PA | Foot & Ankle Surgery | $365.88 |
| Jesse Raszewski | Valdosta, GA | Orthopaedic Surgery | $338.47 |
Prescribed Biofoam?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.